title: Timeliness of care and prognosis in patients with lung cancer.
abstract: BACKGROUND
  Timeliness of care is an important dimension of health care quality. The determining factors of less timely care and their influence on the survival of patients with lung cancer (LC) remain uncertain.
  
  
  OBJECTIVE
  To analyse the delays in the diagnosis and treatment of LC in our health area, the factors associated with the timeliness of care and their possible relationship with the survival of these patients.
  
  
  METHODS
  A retrospective study was conducted on all patients with a cytohistologically confirmed diagnosis of LC between 1 June 2005 and 31 May 2008. The time delays for consultation (specialist delay), diagnosis (diagnosis delay), and treatment (treatment delay), were analysed, as well as the factors associated with these delays and the influence of the timeliness of care on survival.
  
  
  RESULTS
  A total of 307 cases were included (87 % males). The mean specialist delay was 53.6 days (median 35 days), diagnosis delay 31.5 days (median 18 days), treatment delay 23.5 days (median 14 days). The greater age of the patient and a more advanced stage were associated with a shorter specialist delay. Male sex, a more advanced stage, and poor general status were associated with a shorter treatment delay. The survival is longer in patients with a longer treatment delay.
  
  
  CONCLUSIONS
  The delay in the diagnosis in our population seems to be excessively long. The greater the age, a more advanced tumour stage, male sex, and poor general health status are associated with shorter delays. A longer treatment delay is associated with a longer survival.
authors.affiliation: Servicio de Neumología, Hospital Clínico-Universitario, C/Choupana SN, 15706, Santiago de Compostela, Spain, francisco.javier.gonzalez.barcala@sergas.es.
authors.forename: F J
authors.initials: FJ
authors.lastname: Gonzalez-Barcala
authors.forename: J A
authors.initials: JA
authors.lastname: Falagan
authors.forename: J M
authors.initials: JM
authors.lastname: Garcia-Prim
authors.forename: L
authors.initials: L
authors.lastname: Valdes
authors.forename: J M
authors.initials: JM
authors.lastname: Carreira
authors.forename: A
authors.initials: A
authors.lastname: Puga
authors.forename: P
authors.initials: P
authors.lastname: Martín-Lancharro
authors.forename: M T
authors.initials: MT
authors.lastname: Garcia-Sanz
authors.forename: D
authors.initials: D
authors.lastname: Anton-Sanmartin
authors.forename: J C
authors.initials: JC
authors.lastname: Canive-Gomez
authors.forename: A
authors.initials: A
authors.lastname: Pose-Reino
authors.forename: R
authors.initials: R
authors.lastname: Lopez-Lopez
mesh_terms: D000367:Age Factors; D000368:Aged; D057210:Delayed Diagnosis; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000175:diagnosis* / Q000401:mortality / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D012017:Referral and Consultation; D012189:Retrospective Studies; D012907:Smoking / Q000453:epidemiology; D013997:Time Factors